Learning hub
Scientific and Clinical Updates
Explore a comprehensive collection of educational resources designed to enhance your understanding and management of various type 2 inflammatory diseases.
Each learning hub page functions as a centralized repository of information for a specific therapeutic area, meticulously organized by key topics relevant to your clinical practice, such as pathophysiology, burden of disease, and disease management strategies. Delve into the underlying mechanisms, assess the clinical impact, and review current best practices for patient care.
To support learning and self-assessment, each hub includes a quiz section, allowing you to gauge your understanding of the key concepts and principles.
Begin by selecting your area of interest below.
Learning Hub
COPD, a progressive respiratory condition, is defined by persistent airflow limitation and a spectrum of clinical presentations. There are multifaceted factors that contribute to its development and progression including complex inflammatory processes that drive the disease's pathogenesis. A profound understanding of COPD's inherent heterogeneity recognizing that it is not a singular disease, but rather a collection of phenotypes with varying underlying mechanisms and responses to treatment is crucial for advancing personalized patient care.
CRSwNP is a chronic type 2 inflammatory disease characterized by inflammation and polyp formation that obstructs the sinus and nasal passages. It presents as nasal obstruction, rhinorrhea (nasal discharge), facial pain/pressure, and reduced or complete loss of smell. The persistent symptoms can lead to breathing difficulties, sleep disturbances including snoring, chronic fatigue, and significant reduction in quality of life.
Access the resources below to gain better understanding on a variety of topics related to CRSwNP.
Type 2 asthma is a common phenotype of asthma, characterized by key cytokines IL-4, IL-13, and IL-5, as well as elevated type 2 inflammatory biomarkers as FeNO, and eosinophils, or the need for maintenance OCS. Type 2 inflammation is evident in up to 88% of patients with severe asthma, representing a substantial portion of the disease burden associated with asthma. Explore the resources below better understand the role of type 2 inflammation in asthma.
Atopic dermatitis (AD) is a chronic, relapsing, systemic disease with a high impact on the lives of patients and caregivers that requires early intervention and long-term disease control. View resources below to learn more about a variety of topics related to AD.
